A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lara Dunn, Eric Jeffrey Sherman, Alan Loh Ho, Ian Ganly, Nadeem Riaz, Luc Morris, Kin Wai (Tony) Hung, Anuja Kriplani, Jennifer R. Cracchiolo, Marc Cohen, Jay Boyle, Snehal G. Patel, Sofia Haque, Nora Katabi, Ronald A Ghossein, Sean Matthew McBride, Loren S. Michel, Richard J. Wong, Nancy Y. Lee, David G. Pfister
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Regeneron Pharmaceuticals
OpenAlex ID: W4286298969